- Report
- August 2025
- 190 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- February 2026
Global
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
North America
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
Middle East
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
Asia Pacific
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
China
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
United States
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
United Kingdom
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
Europe
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
Europe
From €3490EUR$3,990USD£3,011GBP
- Report
- February 2026
Global
From €3490EUR$3,990USD£3,011GBP
The antiserum market within the context of coagulation and hemostasis testing is a segment of the in-vitro diagnostics industry. It is composed of products used to detect and measure the activity of clotting factors in the blood. These products are used to diagnose and monitor a variety of conditions, including hemophilia, thrombosis, and other bleeding disorders. Antisera are used to detect the presence of specific clotting factors in the blood, and to measure their activity. They are also used to detect the presence of antibodies that may interfere with the clotting process.
The antiserum market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Siemens Healthineers, Abbott Laboratories, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and Sysmex Corporation. Show Less Read more